RGLS logo

Regulus Therapeutics (RGLS) CAPEX

annual CAPEX:

N/A
December 31, 2024

Summary

  • RGLS annual capital expenditures is not available.

Performance

RGLS CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherRGLScash flow metrics

quarterly CAPEX:

N/A
March 31, 2025

Summary

  • RGLS quarterly capital expenditures is not available.

Performance

RGLS quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherRGLScash flow metrics

TTM CAPEX:

N/A
March 31, 2025

Summary

  • RGLS TTM capital expenditures is not available.

Performance

RGLS TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherRGLScash flow metrics

RGLS CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

RGLS CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

RGLS CAPEX History

DateAnnualQuarterlyTTM
Dec 2020
$11.00K(-95.5%)
$0.00(-100.0%)
$11.00K(-84.3%)
Sep 2020
-
$11.00K(-81.4%)
$70.00K(-71.3%)
Dec 2019
$244.00K(+1009.1%)
$59.00K(-66.7%)
$244.00K(+31.9%)
Sep 2019
-
$177.00K(+2112.5%)
$185.00K(+516.7%)
Jun 2019
-
$8000.00(>+9900.0%)
$30.00K(+36.4%)
Dec 2018
$22.00K(-93.1%)
$0.00(-100.0%)
$22.00K(-79.6%)
Sep 2018
-
$22.00K(-74.4%)
$108.00K(-66.1%)
Dec 2017
$319.00K(-67.0%)
$86.00K(-7.5%)
$319.00K(-21.2%)
Sep 2017
-
$93.00K(-720.0%)
$405.00K(-49.8%)
Jun 2017
-
-$15.00K(-109.7%)
$806.00K(+12.7%)
Mar 2017
-
$155.00K(-9.9%)
$715.00K(-26.0%)
Dec 2016
$966.00K(-32.4%)
$172.00K(-65.2%)
$966.00K(-26.3%)
Sep 2016
-
$494.00K(-566.0%)
$1.31M(+0.8%)
Jun 2016
-
-$106.00K(-126.1%)
$1.30M(-18.3%)
Mar 2016
-
$406.00K(-21.5%)
$1.59M(+11.4%)
Dec 2015
$1.43M
$517.00K(+6.8%)
$1.43M(+50.4%)
DateAnnualQuarterlyTTM
Sep 2015
-
$484.00K(+160.2%)
$951.00K(+8.7%)
Jun 2015
-
$186.00K(-23.5%)
$875.00K(-36.5%)
Mar 2015
-
$243.00K(+539.5%)
$1.38M(+13.9%)
Dec 2014
$1.21M(+45.0%)
$38.00K(-90.7%)
$1.21M(-10.6%)
Sep 2014
-
$408.00K(-40.9%)
$1.35M(+9.5%)
Jun 2014
-
$690.00K(+820.0%)
$1.24M(+53.3%)
Mar 2014
-
$75.00K(-58.6%)
$806.00K(-3.5%)
Dec 2013
$835.00K(-41.4%)
$181.00K(-37.6%)
$835.00K(-28.7%)
Sep 2013
-
$290.00K(+11.5%)
$1.17M(+26.5%)
Jun 2013
-
$260.00K(+150.0%)
$926.00K(-19.8%)
Mar 2013
-
$104.00K(-79.9%)
$1.15M(-19.1%)
Dec 2012
$1.43M(+138.5%)
$517.00K(+1048.9%)
$1.43M(+56.9%)
Sep 2012
-
$45.00K(-90.8%)
$909.00K(+5.2%)
Jun 2012
-
$488.00K(+29.8%)
$864.00K(+129.8%)
Mar 2012
-
$376.00K
$376.00K
Dec 2011
$598.00K(-75.2%)
-
-
Dec 2010
$2.42M
-
-

FAQ

  • What is the all time high annual CAPEX for Regulus Therapeutics?
  • What is the all time high quarterly CAPEX for Regulus Therapeutics?
  • What is the all time high TTM CAPEX for Regulus Therapeutics?

What is the all time high annual CAPEX for Regulus Therapeutics?

Regulus Therapeutics all-time high annual capital expenditures is $2.42M

What is the all time high quarterly CAPEX for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly capital expenditures is $690.00K

What is the all time high TTM CAPEX for Regulus Therapeutics?

Regulus Therapeutics all-time high TTM capital expenditures is $1.59M
On this page